SFMG Wealth Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$401K Buy
1,028
+200
+24% +$84.6K 0.02% 223
2026
Q1
$392K Hold
828
0.03% 218
2025
Q4
$386K Hold
828
0.03% 213
2025
Q3
$353K Hold
828
0.02% 213
2025
Q2
$317K Hold
828
0.02% 203
2025
Q1
$286K Buy
828
+4
+0.5% +$1.29K 0.02% 206
2024
Q4
$247K Hold
824
0.02% 224
2024
Q3
$335K Sell
824
-27
-3% -$9.88K 0.03% 187
2024
Q2
$273K Buy
851
+5
+0.6% +$1.63K 0.02% 204
2024
Q1
$282K Buy
846
+5
+0.6% +$1.53K 0.02% 203
2023
Q4
$228K Sell
841
-6
-0.7% -$1.48K 0.02% 223
2023
Q3
$208K Buy
847
+1
+0.1% +$274 0.02% 219
2023
Q2
$257K Buy
846
+27
+3% +$7.51K 0.03% 194
2023
Q1
$216K Buy
+819
New +$208K 0.02% 220
2022
Q1
Sell
-913
Closed -$235K 310
2021
Q4
$235K Hold
913
0.02% 245
2021
Q3
$222K Buy
+913
New +$223K 0.02% 226

Other funds holding HCA

SFMG Wealth Advisors's HCA Position: Q2 2026 in Review

SFMG Wealth Advisors increased its HCA Healthcare (HCA) stake by 24% in Q2 2026, buying an estimated $84.6K and bringing the position to 1,028 shares worth $401K. The position accounts for 0.02% of the portfolio, ranked #223.

SFMG Wealth Advisors first reported a position in HCA in Q3 2021 and has held it in 16 quarters since. 1,339 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • SFMG Wealth Advisors held 1,028 shares of HCA Healthcare worth $401K as of Q2 2026.
  • SFMG Wealth Advisors bought 200 HCA Healthcare shares in Q2 2026, an estimated $84.6K.
  • HCA Healthcare made up 0.02% of SFMG Wealth Advisors's portfolio in Q2 2026, its #223 holding.
  • SFMG Wealth Advisors first reported a position in HCA Healthcare in Q3 2021 and has held it in 16 quarters since.
  • 1,339 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on SFMG Wealth Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.